A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and Taiwan

NCT05512819 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

541

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Disease

Interventions

BIOLOGICAL: 20-valent pneumococcal conjugate vaccine
BIOLOGICAL: 13-valent pneumococcal conjugate vaccine

Sponsor

Pfizer